AstraZeneca's bold vision for a cutting-edge vaccine facility in Speke is caught in a web of delays, leaving the biotech ...
AstraZeneca is backing up its considerable ... investment in an expansion of its vaccines manufacturing facility in Speke, near Liverpool, and a new facility at its R&D headquarters in Cambridge ...
Hosted on MSN5mon
AstraZeneca may relocate its vaccine manufacturing from the UK to the US after negotiations with new labour government failAstraZeneca spokesperson commented "We are committed to pursuing the opportunity at Speke and are in constructive discussions with the UK government." The spokesperson further added, "We have no ...
The pharmaceutical giant said in March that it would invest £450m into a new green vaccine production factory in Speke, Liverpool. AstraZeneca had been in talks with the previous Conservative ...
A £650 million investment package by AstraZeneca in the UK has been held ... to invest £450 million at its manufacturing site in Speke, Liverpool, to boost research, development, and ...
AstraZeneca has updated the efficacy result of its coronavirus vaccine trial in the US, after health officials insisted they wanted to include the latest information. The Anglo-Swedish firm has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback